clopenthixol has been researched along with Dyskinesia, Drug-Induced in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (16.67) | 18.7374 |
1990's | 7 (58.33) | 18.2507 |
2000's | 3 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kumar, A; Strech, D | 1 |
Buschman, HP; Hariz, M; Kölling, P; Lenders, MW; Steur, EN; Vergouwen, MD | 1 |
Jensen, J; Jensen, NB | 1 |
Coupland, N; Nutt, O | 1 |
Beauclair, L; Chouinard, G; Safadi, G | 1 |
Gerlach, J; Larsen, EB | 1 |
Dahl, ML; Jaanson, P; Kiivet, RA; Marandi, T; Svensson, JO; Vään, S; Vasar, V | 1 |
Gerlach, J; Hagert, U; Lublin, H; Meidahl, B; Mølbjerg, C; Pedersen, V; Rendtorff, C; Tolvanen, E | 1 |
Chakravarti, SK; Muthu, A; Muthu, PK; Naik, P; Pinto, RT | 1 |
Kemperman, CJ; van den Hoofdakker, RH | 1 |
Allerup, P; Bolwig, TG; Glenthøj, B; Hemmingsen, R | 1 |
Knudsen, P | 1 |
1 review(s) available for clopenthixol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Zuclopenthixol dihydrochloride for schizophrenia.
Topics: Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Randomized Controlled Trials as Topic; Risperidone; Schizophrenia; Schizophrenic Psychology; Sulpiride | 2009 |
2 trial(s) available for clopenthixol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
A double-blind controlled study of intramuscular zuclopenthixol acetate and liquid oral haloperidol in the treatment of schizophrenic patients with acute exacerbation.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Antipsychotic Agents; Arousal; Clopenthixol; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Male; Middle Aged; Neurologic Examination; Prolactin; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology | 1994 |
Zuclopenthixol, a combined dopamine D1/D2 antagonist, versus haloperidol, a dopamine D2 antagonist, in tardive dyskinesia.
Topics: Adult; Aged; Clopenthixol; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Parkinson Disease, Secondary; Psychiatric Status Rating Scales; Psychotic Disorders | 1991 |
9 other study(ies) available for clopenthixol and Dyskinesia, Drug-Induced
Article | Year |
---|---|
Long term results of unilateral posteroventral pallidotomy for antipsychotic drug induced tardive dyskinesia.
Topics: Athetosis; Chorea; Clopenthixol; Delayed-Action Preparations; Dominance, Cerebral; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Follow-Up Studies; Globus Pallidus; Haloperidol; Humans; Male; Middle Aged; Myoclonus; Neurologic Examination; Outcome Assessment, Health Care; Schizophrenia; Treatment Outcome | 2005 |
[Respiratory dyskinesia with hyperventilation].
Topics: Aged; Clopenthixol; Dyskinesia, Drug-Induced; Female; Humans; Hyperventilation; Respiration Disorders; Thiethylperazine; Thioxanthenes | 1983 |
Successful treatment of tardive oculogyric spasms with vitamin E.
Topics: Adult; Anti-Dyskinesia Agents; Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Humans; Male; Schizophrenia; Vitamin E | 1995 |
Subjective experience of treatment, side-effects, mental state and quality of life in chronic schizophrenic out-patients treated with depot neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Male; Middle Aged; Neurologic Examination; Perphenazine; Psychiatric Status Rating Scales; Quality of Life; Schizophrenia; Sick Role | 1996 |
Maintenance therapy with zuclopenthixol decanoate: associations between plasma concentrations, neurological side effects and CYP2D6 genotype.
Topics: Adult; Aged; Analysis of Variance; Chi-Square Distribution; Clopenthixol; Confidence Intervals; Cytochrome P-450 CYP2D6; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Odds Ratio; Parkinsonian Disorders; Polymorphism, Genetic; Regression Analysis; Schizophrenia | 2002 |
Zuclopenthixol acetate (5% in 'Viscoleo'): single-dose treatment for acutely disturbed psychotic patients.
Topics: Adult; Antipsychotic Agents; Clopenthixol; Dyskinesia, Drug-Induced; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Thioxanthenes | 1990 |
Neuroleptic malignant syndrome (NMS): challenge with zuclopenthixol and follow-up--a case report.
Topics: Adult; Clopenthixol; Dyskinesia, Drug-Induced; Electroencephalography; Female; Haloperidol; Humans; Neuroleptic Malignant Syndrome; Psychiatric Status Rating Scales; Psychotic Disorders; Trifluoperazine | 1990 |
Intermittent versus continuous neuroleptic treatment in a rat model.
Topics: Animals; Behavior, Animal; Clopenthixol; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Male; Mastication; Random Allocation; Rats; Rats, Inbred Strains | 1990 |
Chemotherapy with neuroleptics. Clinical and pharmacokinetic aspects with a particular view to depot preparations.
Topics: Administration, Oral; Antipsychotic Agents; Clopenthixol; Delayed-Action Preparations; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Flupenthixol; Fluphenazine; Haloperidol; Humans; Kinetics; Long-Term Care; Patient Compliance; Perphenazine; Schizophrenia; Schizophrenic Psychology; Thiazines | 1985 |